Elevance Health, Inc.·4

Mar 4, 4:56 PM ET

BOUDREAUX GAIL 4

4 · Elevance Health, Inc. · Filed Mar 4, 2026

Insider Transaction Report

Form 4
Period: 2026-03-02
BOUDREAUX GAIL
DirectorPresident and CEO
Transactions
  • Tax Payment

    Common Stock

    [F1]
    2026-03-02$294.07/sh6,713$1,974,092144,307 total
  • Award

    Common Stock

    [F2]
    2026-03-02+16,153160,460 total
  • Award

    Common Stock

    [F3]
    2026-03-02+10,527170,987 total
  • Tax Payment

    Common Stock

    [F1]
    2026-03-03$284.03/sh1,736$493,076169,251 total
  • Award

    Employee Stock Option (Right to Buy)

    [F4]
    2026-03-02+63,81863,818 total
    Exercise: $294.07Exp: 2036-03-02Common Stock (63,818 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    60
Footnotes (4)
  • [F1]PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
  • [F2]Represents restricted share units. Restrictions lapse as follows: 5,384 shares each on 3/2/2027 and 3/2/2028 and 5,385 shares on 3/2/2029.
  • [F3]Represents performance based restricted share units. Restrictions lapsed on 3/2/2026.
  • [F4]The option represents a right to purchase a total of 63,818 shares, and is exercisable in three annual installments, with one installment of 21,272 shares and two installments of 21,273 shares each, beginning on 3/2/2027, which is the one-year anniversary of the option grant date.
Signature
/s/ Kathleen S. Kiefer, Attorney in fact|2026-03-04

Documents

1 file
  • 4
    wk-form4_1772661402.xmlPrimary

    FORM 4